| P2093 | author name string | Arnesen H | |
| | Schumacher A | |
| | Otterstad JE | |
| | Seljeflot I | |
| | Lerkerød AB | |
| | Sommervoll L | |
| P2860 | cites work | Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease | Q37880979 |
| | Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 |
| | Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response | Q37884521 |
| | Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 |
| | Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 |
| | Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 |
| | Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. | Q41027971 |
| | Increased levels of markers of vascular inflammation in patients with coronary heart disease | Q43987411 |
| | Detection and localization of tumor necrosis factor in human atheroma | Q46152807 |
| | Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline | Q78030770 |
| | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology | Q33935019 |
| | Chlamydia pneumoniae in atherosclerotic tissue | Q33935024 |
| | Chlamydia pneumoniae-induced atherosclerosis in a rabbit model | Q33935073 |
| | Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals | Q33972282 |
| | Tumor necrosis factor-alpha in human arterial wall with atherosclerosis | Q34700760 |
| | Cytokines and endothelial cell biology | Q36565690 |
| | Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response | Q37879844 |
| | A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 |
| | Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 |
| P433 | issue | 1 | |
| P921 | main subject | serology | Q502159 |
| | Chlamydia pneumoniae | Q62869737 |
| P304 | page(s) | 153-160 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease | |
| P478 | volume | 164 | |